In breast cancer, CD147 is frequently overexpressed and significantly contributes to tumor progression by promoting the production of matrix metalloproteinase 9 (MMP-9), which degrades the extracellular matrix, and vascular endothelial growth factor (VEGF), which supports angiogenesis [12,13]. This evidence concerns the gene MMP9 and breast carcinoma.